Nonestrogen Treatments for Menopause

EP: 1.Overview of KNDy neurons

EP: 2.VMS Symptoms and Neurokinin Receptor Antagonists

EP: 3.Neurokinin and Estrogen Balance in Menopausal Hot Flashes for Primary Care

EP: 4.Fezolinetant Guidelines and Emerging Data on Menopause and Liver Health

EP: 5.Molecular Comparison and Safety Profiles of Fezolinetant and Elinzanetant

EP: 6.Malignancy Risks of Neurokinin Receptor Antagonists

EP: 7.Guidance for PCPs: Streamlining Menopause Care

Now Viewing

EP: 8.Nonestrogen Treatments for Menopause

EP: 9.VMS Treatment Guidelines

Individualized therapy with shared decision-making is essential when evaluating the risk-benefit profile of hormonal therapy. What are some key considerations for a woman taking hormonal therapy?

• If a woman is not a candidate for hormonal therapy, or elects not to use it, what are some of the therapies/options available to her?

• What nonhormonal therapies are recommended by the North American Menopause Society?
  • What is the importance of Level I evidence and consensus opinions?
• Are we moving toward a more holistic view of the evidence for all available therapies (both hormonal and nonhormonal)?
• Which of these are FDA approved?